Overview

Noise-Induced Hearing Loss-Acute Exposure Treatment (UA)

Status:
Not yet recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of zonisamide (ZNS) for the treatment of noise-induced hearing loss in adults.
Phase:
Phase 2
Details
Lead Sponsor:
Washington University School of Medicine
Collaborators:
Gateway Biotechnology, Inc.
United States Department of Defense
University of Texas
Treatments:
Zonisamide